






































Fever of unknown origin and splenomegaly
A case report of blood culture negative endocarditis
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Abstract
Rationale:Fever of unknown origin (FUO) can be determined by different conditions amongwhich infectious diseases represent the
main cause.
Patient concerns: A young woman, with a history of aortic stenosis, was admitted to our unit for a month of intermittent fever
associated with a new diastolic heart murmur and splenomegaly. Laboratory tests were negative for infectious screening. The total
body computed tomography (CT) scan excluded abscesses, occulted neoplasia, or lymphadenopathy.
Diagnoses: The transthoracic and transesophageal echocardiogram showed an aortic valve vegetation. Three sets of blood
cultures were negative for all microorganisms tested. According to these findings, Bartonella endocarditis was suspected and the
serology tests performed were positive. Finally, real-time polymerase chain reaction (RT-PCR) detected Bartonella henselae DNA on
tissue valve.
Interventions: The patient underwent heart valve surgery and a treatment of Ampicillin, Gentamicin, and oral Doxycycline was
prescribed for 16 days and, successively, with Doxycycline and Ceftriaxone for 6 weeks.
Outcomes: After surgery and antibiotic therapy, patient continued to do well.
Lessons: Bartonella species are frequently the cause of negative blood culture endocarditis. Molecular biology techniques are the
only useful tool for diagnosis. Valvular replacement is often necessary and antibiotic regimen with Gentamicin and either Ceftriaxone
or Doxycycline is suggested as treatment.
Echocardiogram and blood cultures must be performed in all cases of FUO. When blood cultures are negative and
echocardiographic tools are indicative, early use of Bartonella serology is recommended.
Abbreviations: BCNE = blood culture negative endocarditis, CRP = C-reactive protein, CT = computed tomography, EBV =
Epstein–Barr virus, FUO = fever of unknown origin, HACEK = Haemophilus, Aggregatibacter, Cardiobacterium, Eikenella, Kingella,
HSV = herpes simplex virus, IE = infective endocarditis, RT-PCR = real time-polymerase chain reaction.
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1. Introduction
Fever of unknown origin (FUO) was defined in 1961 by
Petersdorf and Beeson as the following: a temperature greater
than 38.3°C (101°F) on several occasions, more than 3 weeks
duration of illness, and failure to reach a diagnosis despite 1 week
of inpatient investigation. The causes generally recognized are
infections, rheumatic disease, malignancy or other (factitia,
sarcoidosis, drugs). Infections and noninfectious inflammatory
diseases each account for 15% to 35% of FUOs, while
malignancies cause less than 20% of these fevers.[1,2] In the
current case series, cases of FUO that remain undiagnosed
account from 3% to 25%.[2,3]
Infective endocarditis (IE) represent one of the most common
causes of FUO. Even if clinical manifestations of IE are highly
variable, fever is the most common symptom of IE (up to 90% of
cases). It is often associated with chills, anorexia and weight loss,
malaise, headache, myalgias, and arthralgias. Cardiac murmurs
are observed in approximately 85% of patients and supportive
signs include splenomegaly and cutaneous manifestations, such
as petechiae or splinter hemorrhages.
The diagnosis of IE should be suspected in all patients with
fever (with or without bacteremia) in the setting of relevant
cardiac (previous endocarditis, intracardiac devices, pre-existing
valve damage) and noncardiac (such as occupational history,
animal contacts, immunization status) risk factors. The diagnosis
is based on clinical manifestations, blood cultures (or other
microbiologic data), and echocardiography (transthoracic or
transesophageal), according to the accepted modified Duke
criteria.[4]
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Typical microorganisms consistent with IE include Staphylococ-
cus aureus, viridans streptococci, community-acquired enterococci,
Streptococcus gallolyticus, or HACEK (Haemophilus, Aggregati-
bacter, Cardiobacterium, Eikenella, Kingella) organisms.
Blood culture negative endocarditis (BCNE) is defined as
endocarditis without etiology following inoculation of at least 3
independent blood samples in a standard blood-culture system,
with negative cultures after 5 days of incubation and subculturing
and may account for up to 30% of all IE.
Blood cultures may remain negative from 2% up to 7% of
cases, even when the utmost care is taken in obtaining the proper
number and volume of blood cultures.[5] It can be possible for 3
major reasons: previous administration of antimicrobial agents,
inadequate microbiological techniques, or infection with highly
fastidious bacteria or nonbacterial pathogens. Some of pathogens
that can cause BCNE are Bartonella species, which are fastidious
Gram-negative bacilli not growing unless special media or
microbiologic methods are used.
Of the 24 species including the Bartonella genus, Bartonelaa
bacilliformis, Bartonella henselae, and Bartonella quintana
infections are most commonly implicated in human disease,
and B. henselae and B. quintana account for the majority of
morbidity and mortality among immunocompromised individu-
als. They have an identified zoonotic reservoir, in particular, B.
henselae is a zoonosis transmitted from natural reservoir, cats,
usually via cat scratch or bite and less commonly by a vector such
as cat fleas or ticks.
2. Case report
A 54 -year-old woman was admitted to our Department for an
intermittent fever lasted from 1 month, with shivering and
temperature greater than 39.0°C, weight loss, and fatigue.
The patient had a history of aortic stenosis symptomatic for
dyspnea and exertional angina, diagnosed 1 year before, for
which she was evaluated for cardiac elective surgery. The patient
lived and worked on a farm and had continuous contact with
stray animals, including a cat.
Upon admission, she was afebrile and physical examination
revealed a new diastolic heart murmur and splenomegaly.
Routine laboratory tests performed were normal, except for
the evidence of pancytopenia, polyclonal gammopathy, and a
slight rise of transaminases. C-reactive protein (CRP) was 4mg/
dL (normal value <0.5mg/dL), and procalcitonin was 0.30ng/
mL (normal value <2.0ng/mL).
Serology for hepatitis B and C virus, Leptospira, Toxoplasma
Gondii, Cytomegalovirus, Epstein–Barr virus (EBV), and herpes
simplex virus (HSV) were tested and acute infections were
excluded. Finally, serology for HIV infection and Quantiferon
test resulted negative.
A brain–chest–abdomen CT scan showed severe aortic valve’s
stenosis with calcifications and confirmed the presence of severe
splenomegaly, however, not documenting any occulted neo-
plasm, lymphadenopathy, or abscesses (Figs. 1 and 2).
According to ESC Guidelines,[4] a transthoracic echocardio-
gram was performed in order to exclude IE. It showed an aortic
valve diffusely echogenic and altered as for endocarditis, with
Doppler evidence of moderate stenosis and severe insufficiency
(aortic transvalvular gradient of 27mm Hg) with multiple and
variously oriented jets, due to flat valve overhanging. Moreover,
aortic valve ring was disomogeneously thickened as for a
perivalvular abscess and enlargement of left Valsalva sinus.
Thus, a transesophageal echocardiogram was performed in
order to evaluate the perivalvular abscesses. It showed a bicuspid
aortic valve with small floating training in the outflow tract (5
mm) and confirmed the left Valsalva sinus’s aneurysm (the
maximum size of 2111mm; 1.34cm2 area) with dilatation of
right Valsalva sinus too, findings compatible with abscessualized
aortic valve endocarditis.
Three sets of blood cultures collected by BACTEC bottles were
obtained 6hours away from each other and from separate sites.
Then, empiric antimicrobial drug therapy, including Genta-
mycin and Ampicillin, was initiated.
After 5 days of incubation in fresh agar plates maintained in
5% CO2 at 35°C, all blood culture samples resulted negative for
bacterial growth, and no direct microscopy nor subculture of
blood samples were made, as protocol of our Institute’s
microbiology laboratory.
As indicated by ESC Guidelines in case of BCNE,[4]Coxiella
burnetii, Legionella pneumophila, Clamydia pneumoniae, Bru-
cella, Aspergillus, and Bartonella species serology were tested.
Only immunoglobulin G and M for B. henselae were positive,
with a titer of 1/2560 and 1/800, respectively. Then, oral
Doxycycline was prescribed for the treatment of presumed
Bartonella endocarditis.
Given the echocardiographic finding of extensive remodeling
of aortic valve, with fluctuating vegetation, 2 days later, the
patient underwent aortic valve and aortic root replacement due to
the high risk of septic embolization.
Figure 1. Severe splenomegaly at CT abdomen scan.
Figure 2. Extended aortic valve calcification at CT chest scan.
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After surgery, patient received a treatment with Ampicillin,
Gentamicin, and Doxycycline for 16 days and, successively, with
Doxycycline and Ceftriaxone for 6 weeks.
Gram staining, acid-fast staining, and fungal staining of
patient’s aortic valve cups showed that no microorganisms were
present in valvular tissues. Culture analyses of the vegetation and
cardiac valvular tissue samples by recommended techniques[6]
were negative for any bacterial and fungal species after 28 days of
incubation.
Finally, RT-PCR detected B. henselae DNA on tissue valve.
The ethical committee approval was not necessary. Informed
consent was not obtained because the patient was discharged
long before we wrote the case report.
3. Discussion
Bartonella endocarditis accounts for 5% to 30% of all
endocarditis cases.[5] To date, almost all reports have involved
adults and, overall, approximately 85% to 90% of the cases have
involved men.
Available data suggest that homelessness, alcoholism, and
infestation with body lice are associated with B. quintana
endocarditis, whereas contact with cats and previous valvular
disease serve as the major risk factors for B. henselae
endocarditis,[7] as did our patient.
The clinical features are similar to those of patients having
other IE, as described by the Duke Criteria.[4] Affected patients
typically present with subacute, nonspecific symptoms, including
fever, fatigue, weakness, and weight loss. In addition, most
patients have evidence of a murmur on cardiac auscultation.
Such patients typically have an aggressive disease course
characterized by valvular perforation or rapid valvular damage
progression and heart failure. Embolic events have been reported
in some case series, even if available data are inconsistent.[8]
Approximately 90% of patients have involvement of the aortic
valve and, approximately, in 50% of them, there is the evidence
of a preexisting valvular disease.[8]
Our patient presented to us with 1-month-old intermittent
fever with shivering, weight loss, fatigue, and physical examina-
tion revealed a new diastolic murmur and splenomegaly.
Both laboratory tests and chest-abdomenCT scan did not reveal
any clues for diagnosis. Echocardiographic findings were strongly
suspected for endocarditis, but all the 3 sets of blood cultures
performed were negative after 72 to 96hours of incubation.
As indicated by ESC guidelines,[4] serology for Bartonella
infection was performed and resulted positive. Finally, diagnosis
was confirmed by the reply of B. henselae DNA on tissue valve,
after elective surgery.
To date, there is still a lack of criteria for diagnosis of
Bartonella endocarditis. Blood cultures, in fact, are often negative
and the serologic methods currently used are limited by their poor
specificity (in some case series, a cross-reaction between
Bartonella species and Coxiella and Clamydia species was
demonstrated) and by the absence of a defined significant titers,
even if an IgG titer of >800 could be considered significant.[9]
Among molecular biology techniques, RT-PCR represents a
helpful method for demonstrating B. henselae infection, by
detecting bacterial DNA in cardiac valvular tissue, especially
when fresh valvular tissue is used. Furthermore, PCR can
distinguish all of Bartonella species, unlike serological tests.
At present, the optimal antibiotic therapy for Bartonella
endocarditis is unknown, as there are no randomized trials. In
addition, many patients with Bartonella endocarditis have
undergone cardiac valvular surgery with removal of the infected
valve, making it difficult to assess the separate role of antibiotics.
However, treatment guidelines for suspected and proven
Bartonella endocarditis were defined in the 2005 American Heart
Association (AHA) Infective Endocarditis guidelines.[10] Initial
regimen for suspected Bartonella endocarditis should include
Ceftriaxone, Doxycycline, and Gentamicin. After Bartonella
endocarditis was proven, treatment suggested consists of the use
of Doxycycline and Gentamicin for 14 days. After that, patients
should receive an extended course of Doxycycline monotherapy.
The duration of Doxycycline monotherapy depends upon
whether or not cardiac valvular surgery was performed to
remove the infected valve: 6 weeks for patients undergone cardiac
valve surgery and 3 months for those not undergoing surgery.
4. Conclusion
Wediagnosed a native valve endocarditis caused byB. henselae in
a peasant woman by using serology and PCR analysis of surgical
tissue samples. The patient underwent aortic valve replacement
and then received a course of Doxycycline and Ceftriaxone,
continuing to do well.
In conclusion, transthoracic echocardiogram and blood
cultures remain the cornerstone of diagnosis of IE and they
must be performed in all cases of FUO.
Bartonella infection should be included in the differential
diagnosis of culture-negative endocarditis. Early use of Bartonella
serology (as well as Coxiella burnetii, Chlamydia, Legionella,
Aspergillus, and Brucella serology) is recommended in those cases
in which properly obtained blood cultures do not establish the
etiology of the endocarditis. Nonculture techniques such as
serology and PCR analysis of surgical tissue may be the diagnostic
methods of choice given the difficulty in culturing these organisms.
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